Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diagnostics
Lymphoscintigraphy shown to have limited usefulness in staging breast cancer
November 24th, 2005
Lymphoscintigraphy was shown to have limited usefulness in staging breast cancer. According to recent research from the United States, "Sentinel lymph node (SLN) biopsy examination is an accepted method of staging breast cancer patients. SLN biopsy examination in patients with drainage to the internal mammary chain (IMC) nodes is controversial. A prospective study of SLN biopsy examination followed by axillary dissection was analyzed to determine how surgeons manage patients with IMC drainage and the rates of axillary SLN identification and positivity in these cases." "Lymphoscintigraphy was performed in 2196 (53.2%) of the 4131 patients in this...
Source: Women's Health Weekly (2005-11-24)
|
